NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 10 | -97.6% | 0.00% | -100.0% |
| Q2 2021 | $7,000 | -12.5% | 410 | -0.7% | 0.00% | 0.0% |
| Q1 2021 | $8,000 | – | 413 | +3076.9% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 13 | -99.8% | 0.00% | -100.0% |
| Q3 2020 | $94,000 | -7.8% | 5,695 | -0.2% | 0.01% | -23.1% |
| Q1 2020 | $102,000 | -22.1% | 5,708 | -5.8% | 0.01% | -7.1% |
| Q4 2019 | $131,000 | +84.5% | 6,058 | +55.6% | 0.01% | +75.0% |
| Q3 2019 | $71,000 | -48.2% | 3,894 | +1.1% | 0.01% | -46.7% |
| Q2 2019 | $137,000 | +3325.0% | 3,851 | +3219.8% | 0.02% | +1400.0% |
| Q4 2018 | $4,000 | -99.9% | 116 | -57.8% | 0.00% | 0.0% |
| Q2 2017 | $5,000,000 | 0.0% | 275 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $5,000,000 | – | 275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 598,400 | $10,083,000 | 3.98% |
| Opus Point Partners Management, LLC | 348,583 | $5,874,000 | 3.88% |
| Camber Capital Management LP | 3,500,000 | $58,975,000 | 3.81% |
| 1492 Capital Management LLC | 180,601 | $3,043,000 | 2.21% |
| Virtus ETF Advisers LLC | 38,260 | $645,000 | 1.77% |
| Cormorant Asset Management, LP | 765,156 | $12,893,000 | 1.54% |
| Rhenman & Partners Asset Management AB | 581,000 | $9,790,000 | 1.48% |
| Granahan Investment Management | 2,082,155 | $35,084,000 | 1.21% |
| BRIDGER MANAGEMENT, LLC | 1,563,862 | $26,351,000 | 0.87% |
| RICE HALL JAMES & ASSOCIATES, LLC | 899,531 | $15,157,000 | 0.87% |